Forum uniquely brings together leading family offices, their foundations and sovereign wealth fund representatives seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences
Littleton, MA, Feb. 1, 2016 — Amorsa Therapeutics, a preclinical stage, neuropharmaceutical company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place February 15th to February 18th at the Breakers in Palm Beach, Florida. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading family offices, accomplished foundations, research institutions, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. A unique gathering of family offices, Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year.
Michael Moffat, Cavendish co-founder and Chief Executive Officer explains, “The theme of our Palm Beach Forum is a ‘Celebration of Philanthropy, Impact Investing and Innovation that is Changing the World.’ With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Amorsa’s research and scientific insights into the development of improved treatments for nervous system disorders, including moderate-to-severe pain and treatment-resistant depression, positions them to make a major contribution to improving the lives of the millions of patients suffering from these conditions”.
“We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to treating these serious nervous system disorders. Our lead product candidate, a potent non-opioid analgesic, has been designed to safely treat chronic pain and has the potential to help curb the devastating impact of the prescription opioid epidemic”, said Joe Blanchard, Chief Executive Officer. “We welcome the chance to interact with many of world’s most accomplished scientists, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”
Cavendish Global consists of over 200 leading family offices and foundations from around the world with combined assets of over $260 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.
About Amorsa Therapeutics
Amorsa is a preclinical stage, neuropharmaceutical company pioneering the development of improved treatments for nervous system disorders including moderate-to-severe pain and treatment-resistant depression. Founded in 2013, Amorsa has assembled a leadership team that helped build several life science companies and has a highly successful track record in developing novel therapeutic treatments. In addition, Amorsa has attracted leading neuroscience and pain management experts to join our Scientific and Clinical Advisory Board.
Further information is available on the Company’s website, www.amorsatx.com.
About Cavendish Global
Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year.
For more information: http://cavendishglobal.com
For Further Information Contact:
President, Cavendish Global